Looking for a buyer.
Email --@----.com if interested: Established Pharmaceutical Company: Portfolio includes 12 well-known, trusted products for children, adults, and pets. Strong Financial Performance: Estimated to capture $10 million in annual revenue, with an impressive 21% CAGR since 2020. Logistical Efficiency: Strategic improvements identified that could potentially double net income.

listing type
exclusive representation
industry
Healthcare
location
United States
revenue
$11,030,000
ebitda
$3,180,000
proposed price
$24,000,000
SBA eligibility
no
To download teaser or contact poster, please sign in.